Florida Gov. Ron DeSantis is calling out the Biden administration on its decision to revoke emergency use authorization (EUA) for Regeneron and Eli Lilly monoclonal antibody treatments on Monday.
As a result of the move, all monoclonal antibody sites across Florida have been shut down.
“Without a shred of clinical data to support this action, Biden has forced trained medical professionals to choose between treating their patients or breaking the law,” DeSantis said in a press release. “This indefensible edict takes treatment out of the hands of medical professionals and will cost some Americans their lives. There are real-world implications to Biden’s medical authoritarianism – Americans’ access to treatments is now subject to the whims of a failing president.”
TRENDING: Xi’an Variant has China spooked
The Wall Street Journal reports the Food and Drug Administration (FDA) restricted the use of two monoclonal antibody drugs for COVID-19 because the FDA thinks they are unlikely to be effective against the Omicron variant.
After the FDA’s announcement, the Health and Human Services Department said it wasn’t going to include Regeneron Pharmaceuticals Inc.’s Regen-Cov and Eli Lilly & Co.’s bamlanivimab and etesevimab in its latest COVID drug shipments to states.
“The administration is focused on making sure that if an American gets sick with COVID-19, they get a treatment that actually works,” an HHS spokeswoman told The Journal.